Ian Carroll, Ph.D.
Assistant Professor of Medicine at UNC-Chapel Hill
Dr. Carroll’s research studies how intestinal microbes influence gut physiology and behaviors. Dr. Carroll also uses high throughput sequencing of bacterial genes to characterize the enteric microbiota in human subjects with gastrointestinal disease and mouse models of intestinal inflammation. His goal is to develop enteric microbial-based therapies for the treatment of gut diseases.
In germ free conditions, mice have enlarged cecums, blunted villi, and less weight gain per calories consumed. These changes reverse after inoculation. Microbiota influences emotional state in a complex fashion and germ free mice have higher stress and lower anxiety. Stress increases or decreases depending on the species of bacteria added. Emotional changes after inoculation of germ free mice are not observed when the vagus is severed.
In starvation states, as seen in anorexia, microbiota diversity decreases and the relative proportions of species change. These changes appear to perpetuate symptoms in anorexia. A single case study showed fecal transplant leading to weight gain in a human subject and such interventions might have therapeutic potential in the future.
Janelle Arthur, Ph.D.
Assistant Professor of Microbiology and Immunology
UNC-Chapel Hill School of Medicine
Janelle’s group seeks to understand how inflammation alters the pro-carcinogenic capabilities of the microbiota, with the long-term goal of targeting resident microbes as a preventative and therapeutic strategy to lessen inflammation and reduce the risk of colorectal cancer.
They are focus on clinical strains of intestinal E. coli isolated directly from human inflammatory bowel disease (IBD) patients, who are known to experience a high risk of colorectal cancer. Janelle’s goal is to uncover novel microbial targets will enable us to manipulate the intestinal microbiota as a therapeutic target for human digestive diseases and cancer.
Dr. Yong Hui Jiang
Yong-Hui is an Associate Professor of Pediatrics at Duke University. His laboratory investigates the diseases underlying neurodevelopmental disorders including autism. They focus on genes linked to synapse development and behavioral plasticity. They use molecular and behavioral assays in genetically-modified mice that model human diseases. Although their laboratory does not study the gut directly, 9 in 10 children with Autism suffer from GI complications that may be linked to neurodevelopment disorders of the enteric nervous system.
We have a great talk coming up for our September meeting.
Our friend Gastronaut Dr. Nancy Zucker will be sharing her work on “Visceral hypersensitivity: an emerging concept for individuals with eating disorders”. Nancy is an Eating Disorders Specialist and , Associate Professor in Psychiatry and Behavioral Sciences at Duke University.
Here is a recent story in The New York Times highlighting Nancy’s work: http://nyti.ms/1KKXk2T